Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan
Aliment Pharmacol Ther
.
2019 Jul;50(1):113-115.
doi: 10.1111/apt.15303.
Authors
Shih-Chieh Shao
1
2
,
Edward Chia-Cheng Lai
2
3
,
Kai-Cheng Chang
4
,
Yuk-Ying Chan
4
5
,
Hui-Yu Chen
4
,
Rong-Nan Chien
6
Affiliations
1
Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
2
School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
3
Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.
4
Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
5
Department of Pharmaceutical Materials Management, Chang Gung Medical Foundation, Taoyuan, Taiwan.
6
Liver Research Unit, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
PMID:
31184385
DOI:
10.1111/apt.15303
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Drug Interactions
Hepacivirus
Hepatitis C*
Hepatitis C, Chronic*
Humans
Interferons
Taiwan
Substances
Antiviral Agents
Interferons